NOVELTY: a landmark study in phenotyping and endotyping chronic obstructive airway diseases in real clinical practice
- PMID: 34556532
- DOI: 10.1183/13993003.00627-2021
NOVELTY: a landmark study in phenotyping and endotyping chronic obstructive airway diseases in real clinical practice
Conflict of interest statement
Conflict of interest: R. Louis reports grants and personal fees from GSK, AZ, Chiesi and Novartis, personal fees from Sanofi, outside the submitted work; and has a patent “Method for the diagnosis of airway disease inflammatory phenotype” issued. Conflict of interest: G. Louis has nothing to disclose. Conflict of interest: O. Bonhomme has nothing to disclose.
Comment on
-
Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort.Eur Respir J. 2021 Sep 23;58(3):2003927. doi: 10.1183/13993003.03927-2020. Print 2021 Sep. Eur Respir J. 2021. PMID: 33632799 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical